This is a StreetInsider.com Premium Only Page

Gilead Sciences (GILD) – PRNewswire

Mar 5, 2024 07:00 AM RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

Feb 20, 2024 07:00 AM RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication

Dec 20, 2023 08:45 AM RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola

Nov 15, 2023 06:00 AM ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP

Jul 24, 2023 08:00 AM Cognizant and Gilead Extend Partnership with Five-Year Service Agreement Estimated at $800 Million

Dec 9, 2022 08:15 AM Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma

Nov 29, 2022 08:00 AM Thryv Therapeutics Inc. announces the appointment of Pharmaceutical Commercialization Expert Melissa Koomey, M.B.A., to its Board of Directors

Aug 15, 2022 07:15 PM Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories

Jun 4, 2022 08:30 AM Everest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients

Feb 15, 2022 08:32 AM NRx Pharmaceuticals Announces US National Institutes of Health Study of ZYESAMI® (aviptadil) in Critical COVID-19 is Cleared to Complete Full Enrollment

Jan 20, 2022 03:04 PM Guild Esports Signs Exclusive £4.5m Sponsorship Deal with Bitstamp

Nov 12, 2021 06:01 PM S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2021 Review Results

Nov 10, 2021 07:05 PM Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-negative Breast Cancer Meets Primary Overall Respon

Aug 10, 2021 06:48 AM NRx Pharmaceuticals to Ring Nasdaq Closing Bell on August 10, 2021

Jul 12, 2021 11:18 AM NRx Pharmaceuticals Announces Partnership with the Israel Institute for Biological Research to Complete Development and Commercialization of BriLife™ COVID Vaccine

Jun 14, 2021 04:45 PM Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors

May 26, 2021 06:00 AM Satcher Health Leadership Institute At Morehouse School Of Medicine, With Support From Google.org And Gilead Sciences, Launches Health Equity Tracker To Study Racial Health Ine

Apr 14, 2021 09:25 AM Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer

Apr 8, 2021 08:10 PM Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metast

Apr 6, 2021 01:01 AM NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir

Dec 10, 2020 09:20 AM Gilead Sciences to Acquire MYR GmbH

Nov 5, 2020 06:20 AM ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences

Jan 13, 2020 05:45 AM Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences